A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

Clinical trial NCT05980806 · RECRUITING

Trial details

NCT number: NCT05980806
Sponsor: Karyopharm Therapeutics Inc
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelofibrosis Moderate Thrombocytopenia Mild Thrombocytopenia

Start date: 2024-04-22
Primary completion: 2027-06-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.